COURTNEY HARRIS: Open Payments
NPI 1255901963 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 35 payments from 11 companies in 2025. Trend: 2023 $729 · 2024 $247 · 2025 $815
Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $170 |
| ABIOMED | 1 | $131 |
| Grifols USA, LLC | 4 | $96 |
| Regeneron Healthcare Solutions, Inc. | 4 | $89 |
| Viatris Specialty LLC | 4 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $66 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Boston Scientific Corporation | 1 | $58 |
| Lilly USA, LLC | 1 | $21 |
| Verona Pharma, Inc. | 1 | $19 |
Products named: NUCALA, Prolastin-C Liquid, DUPIXENT, YUPELRI, GLASSIA, CDS - MCT/CEM Monitoring, BREZTRI, TRELEGY ELLIPTA.
Industry payments across AR — which companies pay providers there.
